Summary
In a double-blind study, methyldopa was shown to be significantly more effective than placebo in reducing menopausal hot flushes. The median reduction in the number of hot flushes was 38% with placebo and 65% with methyldopa. The active metabolite of methyldopa, alpha-methylnoradrenaline, is an alpha2-adrenoceptor agonist. Since the alpha2-adrenoceptor agonist clonidine also reduces hot flushes, while the alpha2-adrenoceptor antagonist yohimbine produces flushes, it is speculated that menopausal hot flushes might result from a reduced stimulation of alpha2-adrenoceptors, probably in the CNS.
Similar content being viewed by others
References
Hutton JD, Murray MAF, Jacobs HS, James VHT (1978) Relation between plasma oestrone and oestradiol and climacteric symptoms. Lancet 1: 678–681
Clayden JR, Bell JW, Pollard P (1974) Menopausal flushing: Double-blind trial of a non-hormonal medication. Br Med J 1: 409–412
Starke K, Endo T (1976) Presynaptic α-adrenoceptors. Gen Pharmacol 7: 307–312
Starke K, Borowski E, Endo T (1975) Preferential blockade of presynaptic α-adrenoceptors by yohimbine. Eur J Pharmacol 34: 385–388
Garfield SL, Gershon S, Sletten I, Sundland D, Ballon S (1967) Chemically induced anxiety. Int J Neuropsychiatry 3: 426–433
Coope J, Thomson JM, Poller L (1975) Effects of “natural oestrogen” replacement therapy on menopausal symptoms and blood clotting. Br Med J 4: 139–143
Baumgardner SB, Condrea H, Daane TA et al (1978) Replacement estrogen therapy for menopausal vasomotor flushes. Obstet Gynaecol 51: 445–452
Coope J, Williams S, Patterson JS (1978) A study of the effectiveness of propranolol in menopausal hot flushes. Br J Obstet Gynaecol 85: 472–475
Heritage AS, Stumpf WE, Sar M, Grant LD (1980) Brainstem catecholamine neurons are target sites for sex steroid hormones. Science 207: 1377–1379
Fishman J, Norton B (1975) Catechol estrogen formation in the central nervous system of the rat. Endocrinology 96: 1054–1059
Ball P, Knuppen R, Haupt M et al. (1972) Interactions between estrogens and catecholamines. J Clin Endocrinol 34: 736–746
Lloyd T, Weisz J, Breakfield XO (1978) The catechol estrogen, 2-hydroxyestradiol, inhibits catechol-O-methyltransferase activity in neuroblastoma cells. J Neurochem 31: 245–250
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Nesheim, B.I., Sætre, T. Reduction of menopausal hot flushes by methyldopa. Eur J Clin Pharmacol 20, 413–416 (1981). https://doi.org/10.1007/BF00542092
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00542092